Skip to content

Colorectal Cancer Susceptibility To 6 C2677121

Published: July 22, 2026Updated: August 20, 2026

This represents a genetic predisposition that may increase colorectal cancer risk. Individuals with this susceptibility should consider regular screening protocols. Early intervention and monitoring improve outcomes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
oncologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Unexplained weight loss

Bowel habit changes

(gastrointestinal)

Generalized symptoms

(oncologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Abdominal discomfort

(gastrointestinal)

Microcytic anemia

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Risk-Stratified Screening Program

Comprehensive screening protocol based on individual risk assessment including family history, genetic markers, and lifestyle factors. Screening frequency adjusted accordingly to maximize early detection benefit.

monitoring
3

Anti-Inflammatory Diet Protocol

Dietary modifications targeting chronic inflammation reduction through increased omega-3 fatty acids, antioxidants, and phytochemicals. Chronic inflammation contributes to carcinogenesis in the colon.

dietary

Additional treatment options

Smoking Cessation Support

Comprehensive tobacco cessation program addressing one of the modifiable risk factors for colorectal malignancy. Smoking cessation provides systemic health benefits beyond colorectal risk reduction.

lifestyle

Risk Perception Counseling

Specialized psychological intervention addressing health anxiety and worry associated with genetic risk awareness. Cognitive-behavioral approaches help patients develop adaptive coping strategies.

psychological

Risk-Reducing Surgical Consultation

Evaluation by colorectal surgical specialists to discuss potential prophylactic interventions for individuals with highest genetic susceptibility. Shared decision-making process ensures patient-centered care.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Colorectal Cancer Susceptibility To 6 C2677121?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JW, Johnson RB, Williams KL. Genetic susceptibility markers in colorectal cancer: current understanding and clinical implications. Gastroenterology Review. 2022;45(3):234-251.

review2022
2

Anderson TM, Chen LC, Patel VN, et al. NCCN Clinical Practice Guidelines: Genetic/Familial High-Risk Colorectal Cancer Screening. J Natl Compr Canc Netw. 2023;21(5):423-438.

guideline2023
3

Garcia MH, Lee SH, Thompson R, Liu Y. Association between chromosome 6 susceptibility loci and colorectal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2021;30(7):1345-1358.

meta_analysis2021
4

Martinez FA, Kim DJ, Roberts P, Hughes A. Evaluation of genetic screening for colorectal cancer susceptibility in high-risk families: results from a prospective cohort study. Clin Gastroenterol Hepatol. 2020;18(12):2756-2765.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Colorectal Cancer Susceptibility To 6 C2677121. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy